Prion diseases and prion-like protein misfolding diseases involve the accumulation of abnormally aggregated forms of the normal host proteins, such as prion protein and Tau protein. These proteins are special because of their self-duplicating and transmissible characteristics. Such abnormally aggregated proteins mainly formed in neurons, cause the neurons dysfunction, and finally lead to invariably fatal neurodegenerative diseases. Prion diseases appear not only in animals, such as bovine spongiform encephalopathy in cattle and scrapie in sheep, but also in humans, such as Creutzfeldt -Jacob disease, and even the same prion or prion-like proteins can have many different phenotypes. A lot of biological evidence has suggested that the molecular basis for different strains of prions could be hidden in protein conformations, and the misfolded proteins with conformations different from the normal proteins have been proved to be the main cause for protein aggregation. Crowded physiological environments can be imitated in vitro to study how the misfolding of these proteins leads to the diseases in vivo. In this review, we provide an overview of the existing structural information for prion and prion-like proteins, and discuss the post-translational modifications of prion proteins and the difference between prion and other infectious pathogens. We also discuss what makes a misfolded protein become an infectious agent, and show some examples of prion-like protein aggregation, such as Tau protein aggregation and superoxide dismutase 1 aggregation, as well as some cases of prion-like protein aggregation in crowded physiological environments.
Introduction
Over many years of research, prion hypothesis has been proved by many landmark discoveries, which puts forward that a misfolded protein is the main and maybe the only component of this unconventional proteinaceous infectious agent called a prion [1, 2] . Alper et al. [3] have demonstrated that nucleic acids may not exist in the scrapie agent, and found that the infectious agent could not be destroyed by the extreme conditions, such as very high doses of ionizing radiation and ultraviolet. Griffith [4] has proposed three proposals in which a protein could act as the infectious agent that causes scrapie. But they did not provide any experimental evidence. Chronologically, Prusiner and coworkers [5] [6] [7] [8] have isolated the infectious agent, identified it as a protein, termed the word 'prion', and proposed prion as the infectious agent in Scrapie, the prototype of prion disease in sheep. Afterwards, as the evidence accumulates, Prusiner has further proposed the prion hypothesis to explain how a protein can be an infectious agent [1] . But long before the prion concept, scientists all over the world had invested numerous efforts in investigating the Scrapie and related diseases found in other mammalian species [1, 2] .
The presence of the cellular prion protein (PrP C ) on the cell surface is critical for the neurotoxicity of prions [1] , and moreover, PrP C is suggested to play some roles in cell adhesion, regulation of ionic currents at the cell membrane and neuroprotection, and performing function as a receptor for soluble oligomers of the amyloid b peptide (Ab) [9] . In a milestone research, Prusiner and coworkers [6] have isolated PrP 27 -30, the proteinase K-resistant C-terminal core of the full-length pathological prion protein (PrP Sc ). Besides, PrP Sc can also be generated by the method called 'protein misfolding cyclic amplification' [10 -13] . The state of existence of PrP Sc and the protein concentration are proportional to the infectivity titer [8] . These breakthroughs have absolutely changed what we know about prion previously, and then many biologists have devoted themselves to study of the prion protein for its distinctiveness. More importantly, there are also some findings suggesting that infectivity is related to the prion protein structure, and if the structure is destroyed or binding with anti-PrP (prion protein) antibodies, the infectivity is reduced [8] . It has been concluded that the prion protein can exist in two forms: a normal cellular protein PrP C and a pathological isoform PrP Sc [1, 14] . No sequence differences can be detected between the two forms of the protein; but the nature of their distinct properties appears to be enciphered in the conformation adopted by the proteins [14, 15] . PrP C has normal function and PrP Sc can lead to neurodegenerative diseases, and protein quality control system plays an important role in the clearance of PrP Sc [15, 16] .
The Structure and Post-translational Modification of Prion Proteins
The full-length PrP C has a 22-amino acid (aa) signal peptide in the N-terminal. The signal peptide determines the PrP should be exported to the cell surface, and will be cleaved after reaching the membrane. It also has a C-terminal glycosylphosphatidylinositol (GPI) anchor sequence locating after amino acid residue 230 or 231 [1] . It is well known that PrP C is located at the outside membrane through its GPI anchoring, which can be digested by phosphatidylinositol-specific phospholipase C. PrP C has a long NH 2 -proximal flexible random-coil sequence, followed by a globular non-random COOH-proximal domain [17] . The flexible disordered structure of a less-defined NH 2 proximal region consists of the sequence from residues 23 to 124 and contains a stretch of several octapeptide repeats, which is important for PrP binding with metal ions. The N-terminal half of the molecule does not have regular structure at all, whereas the C-terminal half has many normal secondary structure including three a-helices at the residues 144-154, 173-194, and 200-228, and also interspersed with two antiparallel b-sheets formed at residues 128-131 and 161-164. Only a single disulfide bond is found between cysteine residues 179 and 214 [17] . Many important amino acids affect prion protein fibril formation, such as mouse prion protein polymorphism Phe-108/Val-189 [18] , human prion protein polymorphic residue 129 [19] , and the methionine oxidation [20] .
Caughey and coworkers [21] have answered the question what is the most infectious prion protein particles among oligomer, protofibrils, and mature fibrils. After a careful study, they have concluded that it is the oligomer (300 -600 kDa) with masses equivalent to 14 -28 PrP monomer molecules other than fibrillar particles is the most infectious prion protein particles [21] . GPI has been found to play a crucial role in the neuroinvasion and neural spread of prion infection, and is also a key factor in modulating the propagation and spread of prion aggregates [22] [23] [24] [25] . Following inoculation by a peripheral route, glycosylation of PrP C has been found to profoundly influence both the disease timing and the PrP Sc deposition pattern [26] . The same group has also demonstrated that post-translational changes to PrP, such as glycosylation of PrP C , alter transmissible spongiform encephalopathy (TSE) strain properties [27] , and another group has suggested that glycosylation of PrP C is important for efficient trafficking of anchored PrP to the cell surface and sustained prion propagation [28] .
The Difference between Prion and Other Infectious Pathogens
The agent that leads to TSEs is denominated 'prion' by Nobel Prize winner Stanley B. Prusiner [1, 5] and is defined as 'a small proteinaceous infectious particle that is resistant to inactivation by most procedures that modify nucleic acids'. There are several differences between prion and other known infectious pathogens in a few respects. Firstly, although prions may combine with nucleic acid genome longer than 50 bases, the nucleic acid does not contain any hereditary information, and some cofactors such as nucleic acid may have an advantage in prion infectivity. All the information is buried in the conformation of prion [29] . Secondly, the major known component of the prion is a glycosylation modified form of the normal cellular prion protein PrP C encoded by the gene PRNP [1, 5] , and lipid and polysaccharide have also been found in most purified prion rods [29] . Finally, the key event in prion pathogenesis is the conformational conversion of PrP C into PrP Sc . PrP C and PrP Sc differ in many aspects such as solubility, protease-resistant, secondary structure, and infectivity [1, 5] .
It should be explicitly pointed out, while replications of other conventional infectious pathogens require their distinctive nucleic acids, prion does not need nucleic acid to propagate and it does so through its protein conformations. Some recent reports have proved that no nucleic acids are required to propagate infectious prions [30, 31] , supporting this view.
What Makes a Misfolded Protein Become an Infectious Agent?
Firstly, prion protein and the prion-like proteins must trustily and effectively use their misfolded form to self-propagate [4, 32, 33] . Currently the seeding-nucleation mechanism rather than the template-assisted mechanism is preferred in prion-like protein misfolding and aggregation, by which such proteins can replicate their folding characteristics [32, 33] .
Secondly, prion protein and the prion-like proteins must escape from cellular quality control mechanisms [33] . Protein quality control system can help the misfolded proteins regain their biologically active conformation in the assistance of molecular chaperones [16] or degrade such proteins with the help of ubiquitination. For most of proteins, the efficient clearance and the aggregate burden keep a subtle balance via several biological pathways [15, 33] . Such cellular pathways include the unfolded protein response, the endoplasmic reticulum associated protein degradation pathway, and autophagy [33] . However, all the eliminating mechanisms need proteases to degrade the misfolded proteins, and the high protease resistance activity of PrP Sc makes it difficult to degrade, which could be crucial to the efficiency of prion as an infectious agent [7] .
Thirdly, it is well known that proteins must reach the right site at the right time, so that they can exert their normal physiological functions [2, 9] , and this can also be applied to prion protein and prion-like proteins. To produce TSEs, PrP Sc must enter the brain mainly in the nerve cells in quantities that are sufficient to trigger the slow but progressive prion replication process [33] .
Finally, prion protein and prion-like proteins must result in a phenotypic change, including cell apoptosis, organ dysfunction, and neurodegenerative diseases [33] . It is known that the accumulation of misfolded proteins is clearly associated with cytotoxicity, but little is known about the molecular mechanism(s) by which misfolded aggregates cause neurodegenerative diseases. Several hypotheses have been proposed, including loss-of-function hypothesis, inflammation hypothesis, and gain-of-toxic-activity hypothesis [32, 33] .
In brief, losing balance, self-propagation, good location, and gain-of-toxic-activity make a misfolded protein become an infectious agent.
Prion-Like Protein Aggregation
Progressive accumulation of misfolded proteins is the hallmark of several neurodegenerative diseases, including Alzheimer, Parkinson, and Huntington diseases [34] . Aggregation of their native counterparts can be caused through a mechanism that shares similarities with the infectious cycle of the mammalian prion protein's selfperpetuating seeded aggregation and spreading [35] , and finally leads to central nervous system dysfunction through different kinds of models [32] . Evidence for such a prionlike mechanism has now spread to other misfolded proteins, such as Ab and Tau protein [34] . Recent advances in some protein misfolding diseases have indicated that these disparate misfolded proteins may spread from cell to cell, even organ to organ in some cases, through a common prion-like mechanism [32, 33] . Most prion-like proteins can aggregate to form different kinds of amyloid fibrils and thus are associated with a variety of neurodegenerative diseases. However, only prion disease has been established as the sole bona fide infectious disease among these protein misfolding disorders [33] . Some research groups have investigated the mechanisms of prion protein assembly into amyloid, including spontaneous fibril formation and PrP Sc -seeded fibril formation [36, 37] . Eisenberg and Jucker [38] have suggested that more attention should be paid to connect recent discoveries on the molecular properties of prion-like proteins in the amyloid state with observations about pathological tissues and disease states.
In the case of prion disorders, the infectious prion replicates by recruiting the normal prion protein PrP C into the pathological PrP Sc -containing aggregates through inducing a pathological conformation of the native endogenous protein [2, 9] . Beyond infectious prions, the notion of prion-like spreading of misfolded conformations of proteins linked to neurodegenerative diseases has emerged from demonstration of Ab plaque formation in the brains of primates after injection of brain extracts of human Alzheimer disease patients [39] .
Prion-Like Protein Aggregation: Tau Protein Aggregation
The microtubule-associated protein Tau is a disorder protein without exact structure, and the aggregation of Tau protein is one of the major reasons for Alzheimer disease [40] . Human Tau protein can form intracellular paired helical filaments (PHFs) [41, 42] . The PHFs can get through the adjacent cells, then induce fibrillization of intracellular human Tau in these naive recipient cells via direct protein-protein contact [43, 44] . The filaments can form not only by the full-length human Tau protein, but also by the three repeated or four repeated Tau segments, and there is cross-seeding and conformational selection between both Tau segments [45] . Following a similar paradigm, intracerebral injection of mutant Tau aggregate-containing brain extracts can cause widespread aggregation of normal human Tau in transgenic mice that do not otherwise develop aggregates [46, 47] , and aggregated Tau can initiate neurofibrillary tangle formation in vivo [48] . Pathological Tau aggregation can be inhibited by some drugs such as phenothiazine [49] , but promoted by the acetylation of Tau [50] . Heparin-induced fibril formation of human Tau in vitro has been quantitatively characterized in our lab recently [51] . We have demonstrated that the fibrillization of human Tau protein is accelerated by low micromolar zinc via bridging of Cys-291 and Cys-322 [52] and enhanced by exposure to lead via interaction with His-330 and His-362 [53] . Furthermore, our very recent results have suggested that fibril-forming motifs play a key role in the fibrillization of human Tau and could be the determinants of amyloidogenic proteins tending to misfold, thereby causing the initiation and development of neurodegenerative diseases [54] . detected in cerebrospinal fluid of ALS patients [57] . The success of SOD1 immunotherapy in transgenic mice has clearly established the pathophysiological importance of extracellular SOD1 in ALS [58] . These features are compatible with the hypothesis that SOD1-misfolding pathology might spread from the site of disease onset to neighboring cells. Recently, it has been reported that aggregates composed of an ALS-causing SOD1 mutant penetrate inside cells by macropinocytosis and rapidly exit the macropinocytic compartment to nucleate aggregation of the cytosolic, otherwise soluble, mutant SOD1 protein [59] . Expression of the enzymatically inactive, natural familial ALS SOD1 mutants in human neural cell lines induces misfolding of wild-type natively structured SOD1 [60] . Oxidized wild-type SOD1, an aberrant wild-type SOD1 species, has been reported to exist in motor neurons from sporadic ALS patients [61] . It has been identified that an over-oxidized SOD1 that recapitulates mutant SOD1-like properties and damages [62] , but whether this oxidized wild-type SOD1 can seed and propagate in cells is still a question. Furthermore, Valentine's lab has found that a small amount of disulfide-reduced apo-SOD1 can rapidly initiate the fibrillization of this exceptionally stable and highly structured protein under mild physiological conditions [63] . Once initiated, the aggregation of SOD1 is self-perpetuating by the recruitment of either apo-or partially metallated disulfide-intact SOD1 [63] .
Prion-like Protein Aggregation in Crowded Physiological Environments
It is known that in vivo human prion protein and its pathogenic mutants, human Tau protein and its pathogenic mutants, and human SOD1 pathogenic mutants have the tendency to form amyloid deposits in many different kinds of tissue and they are associated with different kinds of neurodegenerative diseases [64] . However, it is hard to distinguish the factors that affect prion-like protein aggregation in vivo because of the interaction network between proteins and proteins, proteins and nucleic acids, and so on. Therefore, it is necessary to imitate crowded physiological environments where prion-like protein aggregation takes place by the addition of macromolecular crowding agents in vitro [64] [65] [66] [67] . In macromolecular crowding environments, choosing the right crowders is the key event. The crowders we chose must be very stable and do not interact with its target proteins. Ficoll 70 and dextran 70 are the most widely used polysaccharide crowders [64 -67] , and bovine serum albumin (BSA) and hen egg white lysozyme are the most widely used protein crowders. However, in a recent study, the chaperone-like activity of BSA has been characterized [68] . Using established assays, the anti-aggregatory and antiamyloid properties of BSA has been demonstrated, and evidence has been provided that these properties arise from specific interactions between BSA and its target proteins [68] . We have just performed some experiments on fibril formation of pathological human prion protein mutants using BSA as the crowding agent, and found that BSA has the chaperone-like activity at low concentrations by inhibiting the fibrillization of the prion protein, but performs the crowding effect at high concentrations by enhancing the fibrillization of the prion protein. In contrast, polysaccharide crowder Ficoll 70 enhanced fibril formation of pathological human prion protein mutant D178N ( Fig. 1) and pathological human SOD1 mutant A4V (Fig. 2) . Such a study is under the way. As shown in Fig. 3 , prion protein is a GPI-anchored cell surface protein and the conversion of PrP from a normal soluble conformation PrP C to its pathogenic conformation PrP Sc is dramatically accelerated by crowded physiological environment containing high concentrations of polysaccharides and collagen. Our data suggested that prion-like proteins associated with neurodegenerative diseases are more inclined to form amyloid fibrils in crowded physiological environments than in dilute solutions [64, 66, 67] . The 'driving power' for fibrillization of prion-like proteins involves both the formation of an intermolecular or intramolecular disulfide bond and non-covalent interactions such as electrostatic interactions, hydrogen bonds, and hydrophobic interactions, which could be enhanced by crowded physiological environments [66] . Fibril formation of pathogenic mutant D178N in the absence and in the presence of Ficoll 70, monitored by ThT fluorescence. 10 mM human PrP mutant D178N was incubated at 378C in phosphate-buffered saline buffer ( pH 7.0) containing 1.0 M guanidine hydrochloride in the absence and presence of crowding agents with continuous shaking at 220 rpm. The empirical Hill equation was fitted to the data and the solid lines represented the best fit. The crowding agent concentrations were 0 (solid square), 50 g/l (solid circle), 100 g/l (solid triangle), and 200 g/l (inverted solid triangle), respectively. The assays were carried out at 378C.
Conclusions
Prion-like misfolding and aggregation are thought to be causal pathogens of some neurodegenerative diseases. It is of high interest to summarize the latest processes in protein misfolding research and compare them with the well-known prion propagation. Here, some new progress in prion and prion-like protein aggregation, as well as the difference between prion and other infectious pathogens is reviewed.
Some new examples of prion-like protein aggregation and some new cases of prion-like protein aggregation in crowded physiological environments are also shown. However, besides prion diseases, there is currently no evidence that any other neurodegenerative disease can be transmitted between individuals through natural routes of transmission/infection. Rather, the term prionoid has been introduced to distinguish these events described here relates to propagation of misfolded proteins within an organism, from bona fide, infectious prions [69] . Nevertheless, the prion-like replication that occurs within affected cells and then transfers from cell to cell provides a molecular pathway for disease spread within the nervous system after focal generation of an initiating misfolding event. This unifying mechanism of neurodegeneration should offer opportunities for therapeutic interventions based on agents that may disrupt the cascade of events leading to the propagation of protein misfolding [32] . Figure 3 Macromolecular crowding accelerates conformational conversion of prion protein Prion protein is a GPI-anchored (white balls) cell surface protein and the conversion of PrP from a normal soluble conformation PrP C (red ribbon diagram, left) to its pathogenic conformation PrP Sc (green ribbon diagram, right) is dramatically accelerated by crowded physiological environment (membrane surface) containing high concentrations of polysaccharides (blue branched lines) and collagen (magenta long sticks).
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Figure 2 Macromolecular crowding enhances fibril formation of pathological human SOD1 mutant
Fibril formation of pathogenic mutant A4V in the absence and in the presence of Ficoll 70, monitored by ThT fluorescence. 20 mM apo-SOD1 mutant A4V was incubated at 378C in 20 mM NaH 2 PO 4 -Na 2 HPO 4 buffer ( pH 7.4) containing 50 mM TCEP and 0.2% NaN 3 in the absence and presence of crowding agents with continuous shaking at 220 rpm. The empirical Hill equation was fitted to the data and the solid lines represented the best fit. The crowding agent concentrations were 0 (solid square), 50 g/l (solid circle), 100 g/l (solid triangle), and 150 g/l (inverted solid triangle), respectively. The assays were carried out at 378C.
